A double-blind, randomised, placebo-controlled, 4‑way cross-over Phase I study to investigate the pharmacokinetics, pharmacodynamics and safety of escalating single doses of E‑52862 in young healthy male and female subjects

Trial Profile

A double-blind, randomised, placebo-controlled, 4‑way cross-over Phase I study to investigate the pharmacokinetics, pharmacodynamics and safety of escalating single doses of E‑52862 in young healthy male and female subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 16 May 2016

At a glance

  • Drugs E 52862 (Primary)
  • Indications Acute pain; Neuropathic pain; Pain
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 16 May 2016 Pooled results of the phase I programme (see profiles 57703, 222641,57701) published in the Mundipharma media release.
    • 06 Sep 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top